Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Melodiol Global Health.
RELATED STOCKHEAD STORIES
News
Market Highlights: Tesla, Alphabet slump after posting results, and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Tuesday wins what Monday lost on the ASX
News
ASX Small Caps Lunch Wrap: Who didn’t think this new format through properly this week?
News
Top 10 at 11: A Canadian land sale and gold, gold, gold are today’s news
News
ASX Small Caps Lunch Wrap: Who called the cops to back out of an online romance last week?
Health & Biotech
ASX Health Stocks: Island to tackle deadly Ebola virus
News
Closing Bell: ASX edges lower, but uranium miners rally on Dutton’s nuclear plants pledge
Health & Biotech
Property valued at up to $12m as Melodiol secures convertible note deal
Health & Biotech
‘Stable, material revenue generating business:’ Melodiol’s Canadian subsidiary maintains strong progress
News
Hot Money Monday: Why the Price Sales Ratio outshines the P/E ratio for comparing early-stage stocks
News
Closing Bell: ASX fleeced as retail stocks plunge; Alliance Nickel soars on great big grant
Health & Biotech
Melodiol’s Mernova thriving in Canada with solid start to quarter, expanded product reach
Health & Biotech
ASX Health Stocks: Neuren’s Q1 DAYBUE sales disappoint; 4DX gets another Medicare reimbursement in US
News
Market Highlights: Shopify, Airbnb drag down Wall Street; and what’s been moving the gold price lately?
Health & Biotech
Melodiol delivers strong revenues in Q1 as US moves to reclassify cannabis
Health & Biotech
